TLR7/8 agonist 3 is a potent TLR7 and TLR8 agonist, extracted from patent WO2016057618 (compound of formula (II))[1].
[1]. Martha A. MILLER, et al. Vaccine compositions and methods of use to treat neonatal subjects.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 5mg | ¥1,598.00 | 现货 | 1 | |
| 10mg | ¥2,397.00 | 现货 | 1 | |
| 25mg | ¥3,859.00 | 现货 | 1 | |
| 50mg | ¥5,243.00 | 现货 | 1 | |
| 10mM (in 1mL DMSO) | ¥1,757.00 | 现货 | 1 |
















TLR7/8 agonist 3 is a potent TLR7 and TLR8 agonist, extracted from patent WO2016057618 (compound of formula (II))[1].
[1]. Martha A. MILLER, et al. Vaccine compositions and methods of use to treat neonatal subjects.